Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Illumina Inc (ILMN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,876,548
  • Shares Outstanding, K 146,907
  • Annual Sales, $ 3,333 M
  • Annual Income, $ 826,000 K
  • 60-Month Beta 1.17
  • Price/Sales 14.06
  • Price/Cash Flow 43.84
  • Price/Book 12.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 1.34
  • Number of Estimates 9
  • High Estimate 1.39
  • Low Estimate 1.30
  • Prior Year 1.45
  • Growth Rate Est. (year over year) -7.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
299.66 +7.48%
on 03/27/19
340.40 -5.39%
on 04/12/19
+13.27 (+4.30%)
since 03/22/19
3-Month
268.62 +19.89%
on 01/30/19
340.40 -5.39%
on 04/12/19
+19.77 (+6.54%)
since 01/23/19
52-Week
226.62 +42.11%
on 04/25/18
372.61 -13.57%
on 09/28/18
+76.21 (+31.00%)
since 04/23/18

Most Recent Stories

More News
3 Medical Product Stocks Set to Beat This Earnings Season

The global medical device space takes significant strides in terms of research and development (R&D) and regulatory progress in the first quarter.

ACB : 9.06 (-1.84%)
GHDX : 65.93 (+3.86%)
ILMN : 322.06 (+0.93%)
MYGN : 32.45 (+1.66%)
NSTG : 25.12 (+5.02%)
ISRG : 500.42 (+1.91%)
PRGO : 49.56 (+1.20%)
Illumina Inc Falls 3.51% on Heavy Volume: Watch For Potential Rebound

Illumina Inc (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $317.94 to a high of $327.90. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $328.40...

ILMN : 322.06 (+0.93%)
Will Solid Consumables Drive Illumina's (ILMN) Q1 Earnings?

Despite ongoing customers' transition from HiSeq consumables to NovaSeq, Illumina's (ILMN) Q1 results are expected to gain from this high throughput suite.

CERN : 63.83 (+1.85%)
SYK : 186.96 (+2.64%)
ILMN : 322.06 (+0.93%)
TMO : 263.92 (+1.86%)
SmarTrend Watching for Potential Pullback in Shares of Illumina Inc After 2.47% Gain

Illumina Inc (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $335.15 to a high of $338.84. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of...

ILMN : 322.06 (+0.93%)
Illumina Inc Rises 2.47% on Heavy Volume: Watch For Potential Pullback

Illumina Inc (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $335.15 to a high of $338.84. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of...

ILMN : 322.06 (+0.93%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.91 (+2.56%)
CELG : 93.67 (+0.27%)
ILMN : 322.06 (+0.93%)
IBB : 106.80 (+2.11%)
ALNY : 87.41 (+5.11%)
XBI : 86.92 (+2.84%)
Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

BBP : 42.52 (+2.82%)
SBIO : 34.65 (+2.88%)
ARKG : 33.18 (+1.97%)
ONCE : 110.60 (unch)
ILMN : 322.06 (+0.93%)
JNJ : 139.90 (+1.50%)
LLY : 117.49 (+1.75%)
NVS : 75.90 (+0.66%)
RHHBY : 32.8900 (+1.26%)
PFE : 39.42 (+1.13%)
XBI : 86.92 (+2.84%)
BTEC : 33.19 (+3.20%)
Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

BBP : 42.52 (+2.82%)
SBIO : 34.65 (+2.88%)
ARKG : 33.18 (+1.97%)
ONCE : 110.60 (unch)
ILMN : 322.06 (+0.93%)
JNJ : 139.90 (+1.50%)
LLY : 117.49 (+1.75%)
NVS : 75.90 (+0.66%)
RHHBY : 32.8900 (+1.26%)
PFE : 39.42 (+1.13%)
XBI : 86.92 (+2.84%)
BTEC : 33.19 (+3.20%)
Recent Analysis Shows Healthcare Trust of America, Illumina, Tucows, Asure Software, Saga Communications, and Miller Industries Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Healthcare Trust of America,...

ASUR : 6.86 (-0.29%)
MLR : 34.21 (+0.21%)
HTA : 27.30 (+1.15%)
ILMN : 322.06 (+0.93%)
TCX : 88.68 (+0.01%)
SGA : 34.88 (+3.07%)
Fluidigm Corp is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (FLDM , ILMN , NEO , BRKR , PACB )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

ILMN : 322.06 (+0.93%)
NEO : 20.17 (+0.95%)
FLDM : 13.14 (+2.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade ILMN with:

Business Summary

Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications...

See More

Key Turning Points

2nd Resistance Point 331.51
1st Resistance Point 326.78
Last Price 322.06
1st Support Level 315.67
2nd Support Level 309.29

See More

52-Week High 372.61
Last Price 322.06
Fibonacci 61.8% 316.84
Fibonacci 50% 299.61
Fibonacci 38.2% 282.39
52-Week Low 226.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar